Question 1

What is Glenmark Pharmaceuticals?

Accepted Answer

Glenmark Pharmaceuticals is a Company.

Question 2

How often does Glenmark Pharmaceuticals appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 16 articles.

Question 3

When was Glenmark Pharmaceuticals first tracked by Ergen?

Accepted Answer

First tracked on Mar 20, 2026.

Question 4

When was Glenmark Pharmaceuticals last mentioned in news?

Accepted Answer

Last active on Jun 15, 2026.

Question 5

What is Glenmark Pharmaceuticals's current news sentiment?

Accepted Answer

Aggregate sentiment score: 35 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Glenmark Pharmaceuticals in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Glenmark Pharmaceuticals?

Accepted Answer

Novo Nordisk Cuts Ozempic, Wegovy Prices in India (Mar 30, 2026, 8 articles).

Question 8

How did the "Novo Nordisk Cuts Ozempic, Wegovy Prices in India" event impact Glenmark Pharmaceuticals?

Accepted Answer

Glenmark Pharmaceuticals is among the Indian companies introducing generic semaglutide, contributing to the increased competition in the market.

Question 9

How did the "Novo Nordisk Semaglutide Patent Expiry in India" event impact Glenmark Pharmaceuticals?

Accepted Answer

Glenmark Pharmaceuticals is mentioned as one of the companies offering semaglutide products in India, contributing to the overall market competition.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.